HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Ajanta Pharma Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 58 filings·Updated 19 Aug 2026
Showing 10 of 58 filings.
19 Aug 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Promoter Ravi Agrawal releases pledge on 6,910 Ajanta Pharma shares (Excess Pledge)

Event Overview

  • Release of pledge on 6,910 Ajanta Pharma equity shares by promoter Ravi Agrawal (Excess Pledge).
Filed 17:41View Source
14 Aug 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Ajanta Pharma promoter pledge released on 54,796 shares by Ravi Agrawal trust

Release of pledge on Ajanta Pharma shares

  • Event: Release of pledge on Ajanta Pharma shares by promoter Ravi Agrawal, trustee.
  • Total shares released: 54,796.
  • Reason: Excess pledge.
  • Dates of release: 6 Aug 2026 to 12 Aug 2026.
  • Company: Ajanta Pharma Limited (BSE/NSE listing).
Filed 12:50View Source
5 Aug 20261 filing
Company UpdateGeneral

Ajanta Pharma announces schedule of analyst/institutional investor meetings for August 2026

Meeting schedule

  • 11–13 Aug 2026: Nuvama India Conference 2026 (Singapore & Hong Kong), one-on-one meetings.
  • 18 Aug 2026: Motilal Annual Global Conference, one-on-one meetings at Grand Hyatt, Santacruz.
  • Schedule subject to change; discussions will be strictly on basis of already published information.
Filed 16:55View Source
31 Jul 20262 filings
Company UpdateCopy of Newspaper Publication

Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication

Filed 12:25View Source
Company UpdateNewspaper Publication

Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.

Filed 12:19View Source
30 Jul 20264 filings
Company UpdateAnalyst / Investor Meet

Ajanta Pharma uploads audio recording of earnings call held on 30 July 2026

Meeting Details

  • Date and time: 30 July 2026 at 4:15 p.m.
  • Format: virtual audio recording of the earnings call.
  • Event/organiser: earnings call for Q1 FY2027 organized by Ajanta Pharma.
  • Purpose: earnings discussion with investors.
  • Availability: recording uploaded on the company website; transcript to be submitted in due course.
Filed 17:38View Source
Company UpdateAllotment of ESOP / ESPS

Pls find enclosed ESOP Allotment

Filed 14:51View Source
Corp. ActionRecord Date

Ajanta Pharma announces record date of 5 August 2026 for 1st interim dividend.

Record date for interim dividend

  • Security: Equity shares of Ajanta Pharma Ltd.
  • Record date: Wednesday, 5 August 2026.
  • Book closure: not applicable.
  • Purpose: determine shareholders for 1st interim dividend.
Filed 14:43View Source
Corp. ActionDividend

Ajanta Pharma declares first interim dividend of Rs 32 per share for FY 2027

Dividend details

  • 1st interim dividend approved for FY 2027.
  • Dividend per share Rs 32 on face value Rs 2.
  • Total payout amount Rs 400 crore.
  • Record date fixed on 5 August 2026.
  • Dividend will be paid on or after 18 August 2026.
Filed 14:42View Source
29 Jul 20261 filing
Insider Trading / SASTDisclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Ajanta Pharma: No material encumbrance creation, invocation, or release disclosed in this excerpt

No encumbrance details

  • No material encumbrance on promoter shares disclosed in this excerpt.
Filed 12:23View Source
Showing 10 of 58 filings